Press Releases

Reviva Announces Full Details of Positive Phase 2 Clinical Trial Results for Acute Schizophrenia

Apr 26, 2021

Reviva Pharmaceuticals Holdings, Inc. Reports 2020 Financial Results and Provides Corporate Update

Mar 22, 2021

Reviva Pharmaceuticals Holdings, Inc. to Present at the Maxim Group Inaugural 2021 Emerging Growth Virtual Conference

Mar 11, 2021

Reviva Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conference

Mar 04, 2021

Reviva Pharmaceuticals, Inc. and Tenzing Acquisition Corp. Complete their Business Combination and Trade as Reviva Pharmaceuticals Holdings, Inc.

Dec 14, 2020

Tenzing Acquisition Corp. and Reviva Pharmaceuticals, Inc. Announce the Appointment of Narayan Prabhu as Chief Financial Officer

Nov 04, 2020

Tenzing Acquisition Corp. and Reviva Pharmaceuticals, Inc. Announce Execution of Definitive Agreement and Plan of Merger for Business Combination

Jul 21, 2020

Reviva Pharmaceuticals Announces Successful Completion of Pre-IND Meeting with FDA on Brilaroxazine for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Jun 03, 2019

Reviva Pharmaceuticals Selected as a Winner of the 2018 Red Herring Top 100 Global Award

Oct 29, 2018

Reviva Pharmaceuticals Chosen as a 2018 Red Herring Top 100 North America Winner

Jun 26, 2018